ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Revenue

ST Pharm had revenue of 66.96B KRW in the quarter ending March 31, 2026, with 27.74% growth. This brings the company's revenue in the last twelve months to 346.22B, up 26.15% year-over-year. In the year 2025, ST Pharm had annual revenue of 331.68B with 21.16% growth.

• Revenue (ttm): 346.22B
• Revenue Growth: +26.15%
• P/S Ratio: 7.35
• Revenue / Employee: 528.58M
• Employees: 655
• Market Cap: 2.55T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	331.68B	57.93B	21.16%
Dec 31, 2024	273.75B	-11.24B	-3.94%
Dec 31, 2023	284.99B	35.67B	14.31%
Dec 31, 2022	249.32B	83.68B	50.52%
Dec 31, 2021	165.64B	41.53B	33.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error